tb: the coventry perspective dr thekli gee university hospitals coventry & warwickshire
TRANSCRIPT
TB: The Coventry perspective
Dr Thekli GeeUniversity Hospitals Coventry & Warwickshire
Outline
TB in Coventry:
• Epidemiology
• Resources
• New diagnostic approaches
Epidemiology
Occurrence
• Nearly a third of the world’s population is infected with TB
• TB kills almost 3 million people per year.
Tuberculosis notifications England & Wales
1913 - 2006
Source: Statutory Notifications of Infectious Diseases (NOIDs)
chemotherapy
BCG vaccination
Coventry TB rate by year 1999-2006
Rate per 100,000 population
0
5
10
15
20
25
30
35
1999 2000 2001 2002 2003 2004 2005 2006
rate
Coventry PCT
West Midlands
England & Wales
Linear (Coventry PCT)
Coventry 2007
Tuberculosis case reports and rates by region/country,
England, Wales and Northern Ireland, 2006
Coventry 2007
Coventry
Why Is TB Increasing?
Why Is TB Increasing?
Multiple contributing factors:• Homelessness• Intravenous drug use• HIV infection• Drug-resistant strains of TB• Reduced TB control and treatment resources• Immigration from high TB prevalence areas
Tuberculosis case reports by place of birth and ethnic group, England, Wales and Northern Ireland, 2001 - 2006
Changing populations
• Coventry City council – 1215 asylum seekers on housing list
• Coventry refugee centre– 8000 asylum seekers & refugees
registered– 1571 registered at Meridian Health Centre
Changing populations
• Afghanistan• Iraq• Iran
• Burundi• Democratic Republic of
Congo • Ethiopia• Eritrea• Somalia• Sudan• Zimbabwe
Resources
Increasing numbers of TB cases
Increased demand on TB services
Impact on resources
• Hospital & community TB services– TB clinic– TB nurse time
• Infection control– Isolation facilities– TB incidents
• Occupational health– Pre-employment screening– HCW contacts
• Laboratory services
Impact on resources
• Hospital & community TB services– TB clinic– TB nurse time
• Infection control– Isolation facilities– TB incidents
• Occupational health– Pre-employment screening– HCW contacts
• Laboratory services
TB incidents at UHCW NHS Trust
• 23 incidents in since January 2007
– 18 Patients• Not isolated early enough / at all during admission• Mostly medical wards• 2 Cardiothoracic ward• 1 haematology day unit
– 5 Health care workers• 3 qualified nurses• 1 nursing student• Ward host
Impact on resources
• Hospital & community TB services– TB clinic– TB nurse time
• Infection control– TB incidents – Isolation facilities
• Occupational health– Pre-employment screening– Annual reminders– HCW contacts
• Laboratory services
2007
Impact on resources
• Hospital & community TB services– TB clinic– TB nurse time
• Infection control– TB incidents – Isolation facilities
• Occupational health– Pre-employment screening– Annual reminders– HCW contacts
• Laboratory services
2006
TB national strategy2004
2006
2007
2007
Controlling TB:
1. Diagnosing primary cases
2. Treating active disease
3. Preventing transmission
4. Identifying secondary cases
5. Controlling latent infection
Current diagnostic test for latent TB
• Diagnosis of latent TB relies on the tuberculin skin test.
• 101 years old– Developed 1907 by
Charles Mantoux
• The oldest diagnostic test still in use.
The skin test enters its 6th decade of use. (Canada 1957)
Tuberculin skin tests
• Mantoux test
• Heaf test
48-72 hours later
No longer available
Tuberculin skin tests• Poor specificity:
– antigenic cross-reactivity • BCG • environmental mycobacteria
• Poor sensitivity: – 75-90% in active disease
• lower in disseminated TB and HIV infection
• Need for return visit – 50% DNA rate
• Operator variability – inoculation & reading
• Painful inflammation & scarring• Boosting effect if used repeatedly
New approaches
TB Interferon- release assays
(TIGRA)
• Principle of TIGRA – Detect IFN- produced by effector T-cells
that recognise M. tuberculosis proteins
ESAT-6 & CFP-10• Absent in BCG• Absent in most non-tuberculous Mycobacteria
– Exceptions: M. marinum, M. kansasii
Two Tests available
T-Spot.TB®
Detects individual effector T-cells that produce IFN- in response to M.tuberculosis antigens
Enzyme linked immunospot technique (ELISPOT).
QuantiFERON Gold®
Measures IFN- in the supernatant of the antigen stimulated cells
Enzyme linked immunosorbant assay technique (ELISA)
T-Spot.TB® Quantiferon Gold®
Sensitivity
Immunocompetent 83-97% 70-89%
Immunocompromised
+ malnourished
+ children
<1% indeterminate results 20-24% indeterminate results
T-Spot.TB® Quantiferon Gold®
Sensitivity
Immunocompetent 83-97% 70-89%
Immunocompromised
+ malnourished
+ children
<1% indeterminate results 20-24% indeterminate results
Specificity 99.99% 98%
T-Spot.TB® Quantiferon Gold®
Sensitivity
Immunocompetent 83-97% 70-89%
Immunocompromised
+ malnourished
+ children
<1% indeterminate results 20-24% indeterminate results
Specificity 99.99% 98%
Cost
(including labour etc)
£55-60
per test
£30
per test
T-Spot.TB® Quantiferon Gold®
Sensitivity
Immunocompetent 83-97% 70-89%
Immunocompromised
+ malnourished
+ children
<1% indeterminate results 20-24% indeterminate results
Specificity 99.99% 98%
Cost
(including labour etc)
£55-60
per test
£30
per test
Problems •Must process within 8 hours of venepuncture
•Expertise in cell separation
•Must process within 8 hours of venepuncture
-in tube assay?
•Not reliable enough in the Immunocompromised & children
Method - T-Spot.TB®
• Specimens must be processed within 8 hours of venepuncture
-ve
+ve
ELISPOT
ELISPOT Reader
Role of TIGRAs
• Detection of latent TB:– TB contacts– Healthcare workers
• New employment screens• Following TB exposure incidents
– Before starting immunosuppression• anti-TNF-α drugs e.g infliximab• Pre-transplantation
• Detection of active extra-pulmonary TB– If difficult to diagnose by conventional methods– Closely competing diagnoses e.g. Sarcoid vs TB
Contact tracing:When to use a TIGRA
– NICE:• Following positive Mantoux test
– Most cost effective– May miss some cases
– CDC• In place of Mantoux test
– Shifts burden of work from TB nurses to lab
Business case
• Laboratory service– 5 day to 6 day service– Warwickshire wide (Network)
• TIGRA– Tspot.TB– Microbiology / Immunology
Summary
• TB increasing in Coventry
• Increased demand on resources
• New approaches considered– e.g. TIGRAs